Objective: To investigate the contribution of the use of neuronavigation together with intraoperative ultrasonography in the surgical treatment of cavernous hemangiomas to the decrease of mortality and morbidity.
INTRODUCTION
Cavernous hemangiomas (CHs), also known as cavernous malformations, cavernous angiomas, or cavernomas, are benign vascular lesions with a thin vessel wall, slow blood flow, and lack of muscle layer that consist of endothelial cells and can not be detected in angiography (1) (2) (3) . Their incidence is 0.3-0.7% in the population, and they constitute 10%-20% of all vascular lesions (4, 5) .
Cavernous hemangiomas are generally found at the supratentorial region (80%). Infratentorial (15%) or spinal (5%) locations are encountered less often (6, 7) .
With regard to the incidence of CH, there is no difference between genders. It can appear at any age, from newborn age to the 9 th decade of life. Its incidence is higher between the 3 rd and 5 th decades of life. The lesions generally present as single lesions, but they can also be multiple lesions. Moreover, in the literature, it has been reported that some cases have inherited CH from family members (8, 9) .
Cavernous hemangiomas can be confused with gliomas, arteriovenous malformations, venous angiomas, thrombosed aneurysms, craniopharyngiomas, meningiomas, metastases, and inflammatory lesions in the differential diagnosis (8, 10) .
Generally, arteries and veins are not seen in the angiography, but very tiny arterioles can sometimes be monitored. No pathological finding can be detected, due to low circulation flow rate and thrombus. On the other hand, large veins, capillaries, and neovascularization can sometimes be found (11, 12) .
Magnetic resonance imaging (MRI) is the most effective imaging technique for the diagnosis of CHs, which appear as areas of mixed signal intensity with a surrounding hypointense rim in T1W MRI. Generally, contrast is not enhanced, but sometimes, mild contrast enhancement can be observed. In bleeding cases, the appearance of popcorn is typical (1) . A hemosiderin-stained gliotic layer, associated with chronic slight bleedings, surrounds the lesion (9) . In computed tomography (CT), CHs are generally seen as iso/hypodense. In contrast-enhanced CT, they involve contrast slightly, but when they are hemorrhagic or calcific, they are seen as hyperdense (9, 11).
Central nervous system CHs typically present with epilepsy, bleeding, or a mass lesion (13) . Moreover, they can lead to headache and focal neurological deficits, depending on the complications, such as their size, location, and bleeding (9) .
Cavernous hemangiomas are often small in size and are located in regions that are difficult to reach. In addition to preoperative identification of the ideal surgical approach, the possibility of intraoperative administration of surgical plan is critical for a succesfull operation (14) .
MATERIALS and METHODS
A total of 73 patients, who were operated on with neuronavigation and intraoperative ultrasonography (IOUS) in the Department of Neurosurgery at the Faculty of Medicine of Erciyes University between June 2000 and September 2010, were evaluated retrospectively.
Surgical Procedure
The cases were assessed with regard to neurological damage associated with surgery and excision of the lesion. Neuronavigation (Vector Vision 2; Brain Lab, Munich, Germany) and 7 MHz probe IOUS (Toshiba; Tosbee, Tokyo, Japan) were used in the study. In order to be able to perform the optimum craniotomy for the lesion, to identify the proper angles for reaching the lesion, and to carry out minimally invasive surgery, skin markers were attached in all cases. Then, cranial MRI was performed, and images were transferred to the data processing unit of neuronavigation. The head was fixed with a Mayfield skull-pin head holder (Mayfield headholder; OMI surgical products, Cincinnati, OH, USA), and registration was performed using skin markers. During the operation, IOUS evaluation was repeated many times. Navigation data were updated with real-time images that were obtained. The brain shift, which resulted from resection and cerebrospinal fluid drainage and led to inconsistency between the location of the lesion and the image, was measured to be between 1.7 mm and 6 mm. Then, it was corrected for a safer surgical process.
Statistical Analysis
The data obtained were analyzed using descriptive statistical techniques.
RESULTS
Sixty-eight of 73 patients underwent surgery for a single intracranial CH, and 5 patients were operated on for multiple intracranial CHs (2 patients with 3 CHs, 3 patients with 2 CHs; 80 intracranial CHs in total).
Of the intracranial CH cases, 33 (median 36.2, minimum 11, maximum 74 years,) were male and 40 (median 34.9, minimum 5, maximum 68 years) were female. Supratentorial localization was observed to be more often in the cases, and CHs were located in the temporal, parietal, and frontal regions, considering their frequencies. The distribution of the lesions according to their localization is shown in Table 1 .
The most common complaint for the lesions with supratentorial localization was epilepsy in 41 of 64 cases (64%). On the other hand, for lesions with infratentorial localization, it was headache in 6 of DISCUSSION Magnetic resonance imaging is the most sensitive and specific non-invasive diagnostic method for the diagnosis of CHs, which are benign vascular lesions that can not be monitored in angiography. The differential diagnosis includes bleeding neoplasms, such as brain metastasis; meningiomas; low-and even high-grade glial tumors; inflammatory lesions, such as cysticercosis and chronic granuloma; arteriovenous malformations; venous angiomas; thrombosed aneurysms, craniopharyngiomas; and rare intracranial lesions, like lipomas (8, 10). Typical clinical symptoms of CH are epilepsy (23%-81%), bleeding (7%-70%), focal neurological deficit (5%-62%), headache, and increased intracranial pressure (8, 13) . The surgical treatment of CH aims to prevent bleeding, to remove hematomas, to reduce mass effects in bleeding cases, and to provide seizure control in epileptic cases (15) . Recently, elective surgery has been recommended for reducing the possible risk of bleeding and neurological damage in young patients (8) . Most CHs are supratentorially located. Epilepsy that occurs in association with epileptogenic activity of blood destruction products around the lesion is the most common clinical symptom in CH cases. In the surgical treatment of epileptic seizures caused by CH, excision of the lesion is generally considered to ensure seizure control in most patients. It is usually agreed that not only the malformation but also the surrounding hemosiderinloaded gliotic area must be removed in order to get the seizure under control in supratentorial lesions (8, 13) .
The main goal of surgical treatment for CHs of the brain stem is to remove the lesion totally and not to cause additional neurological damage. It is unnecessary to attempt to remove the gliotic tissue and hemosiderin ring around the cavity in cases with CHs of the brain stem, and this attempt is contraindicated, due to possible additional damage. There is a consensus on the time of surgery. Many authorities suggest that surgery be performed a few days or weeks after bleeding (in the subacute period), when the patient is stable (16) .
In the literature, the rate of bleeding CHs per year is reported to be approximately 0.25% and 1.3% (17) . Some authors pointed out that the possibility of rebleeding was high in patients having a history of bleeding, and they reported the rate of rebleeding as 30%/ person/ year and 21%/year/lesion. Moreover, rebleeding events can lead to serious neurological deficits (16) . The rate of bleeding was found to be significantly higher in female patients having lesions of the brain stem (8, 13) .
Especially in the surgical treatment of small CHs located in regions that are difficult to reach, sensitive intraoperative application of the surgical plan is critical for a successful operation, as well as identification of the ideal surgical approach (14) .
Neuronavigation has a very important place in the surgery of lesions that are involved in complicated anatomic structures having critical importance, such as the skull base, or that are located in functionally active regions. Particularly in small and deeply located lesions, it helps to plan the incision, to identify the proper place for the craniotomy and the size of the craniotomy flap, to determine the ideal entry angles, to designate the critical anatomic structures, and to protect these structures by establishing anatomical dominance. This contributes to a safer surgical procedure, resulting in minimum neural trauma, total resection, and minimum morbidity and mortality (8, (18) (19) (20) .
The most important disadvantage of neuronavigation is the inconsistency with preoperative navigation images, which results from replacing the lesion and critical anatomic structures associated with brain shift that occurs due to intraoperative tumor resection or cerebrospinal fluid drainage. This creates a need for updating the preoperative image with the intraoperative image (18, 21) .
In today's neurosurgery practice, devices that provide real-time localization of the lesion, such as intraoperative CT, intraoperative MRI, and neuronavigation, are used in order to decrease postoperative morbidity and mortality in cases with lesions located in sensitive areas and deep brain regions. Among these devices, IOUS is a method that is practically and technically reliable and that can provide real-time images, independent of size, in the localization of CHs and in the detection of deeply located lesions. Compared to other techniques performed for intraoperative imaging of the lesion, it is cheaper, and it can help to control the resection border of the lesion and to detect coexisting deep venous anomalies (18, 22) .
IOUS is an alternative technique that is mobile, noninvasive, rapid, and cheaper than intraoperative MRI. With regard to tumor localization, features, and its relationship with critical anatomical points, it provides almost real-time and high-quality images. Furthermore, it helps to control the width of the resection and to update neuronavigation data rapidly. This method gives real-time data, so it ensures objective control of the surgical process.
The time needed for obtaining ultrasonographic images is shorter than that needed for intraoperative MRI. Intraoperative ultrasound can be repeated without interrupting the work-flow during the operation (21, 23) .
CONCLUSION
Wide knowledge and experience are primarily essential for surgical success of CHs. Moreover, safer and more reliable resections can be performed by correcting brain shift, which results from cerebrospinal fluid drainage and which leads to the inconsistency between the real location and the navigation image of the lesion, through the use of neuronavigation, together with IOUS. Thus, postoperative morbidity and mortality can be reduced.
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